The strategy is to establish a corporate vision of growth and transformation from a global healthcare company into a global mid-sized pharmaceutical company and ultimately a global biopharmaceutical company. The aim is to enhance the scale and business position of the company as a whole, rather than focusing on specific products, pipeline assets or R&D methods.